Bank of America
MRNA icon

Bank of America’s Moderna MRNA Stock Holding History

Bank of America’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-609,500
Closed -$15.7M – 8015
2025
Q3 		$15.7M Buy
+609,500
New +$17M ﹤0.01% 2842
2024
Q4 		– Sell
-47,200
Closed -$3.15M – 8322
2024
Q3 		$3.15M Sell
47,200
-12,400
-21% -$1.14M ﹤0.01% 4166
2024
Q2 		$7.08M Buy
59,600
+30,700
+106% +$3.89M ﹤0.01% 3288
2024
Q1 		$3.08M Buy
28,900
+22,700
+366% +$2.29M ﹤0.01% 4081
2023
Q4 		$617K Sell
6,200
-65,000
-91% -$5.47M ﹤0.01% 5347
2023
Q3 		$7.35M Buy
71,200
+10,000
+16% +$1.12M ﹤0.01% 3027
2023
Q2 		$7.44M Sell
61,200
-146,500
-71% -$19.5M ﹤0.01% 3010
2023
Q1 		$31.9M Sell
207,700
-418,400
-67% -$69M ﹤0.01% 1719
2022
Q4 		$112M Sell
626,100
-450,800
-42% -$73.7M 0.01% 832
2022
Q3 		$127M Sell
1,076,900
-373,000
-26% -$56.6M 0.02% 750
2022
Q2 		$207M Sell
1,449,900
-172,500
-11% -$24.7M 0.02% 569
2022
Q1 		$279M Sell
1,622,400
-906,900
-36% -$153M 0.03% 528
2021
Q4 		$642M Sell
2,529,300
-203,300
-7% -$59.4M 0.06% 297
2021
Q3 		$1.05B Buy
2,732,600
+22,000
+0.8% +$8.11M 0.11% 184
2021
Q2 		$637M Buy
2,710,600
+1,758,600
+185% +$314M 0.07% 285
2021
Q1 		$125M Buy
952,000
+754,900
+383% +$109M 0.01% 786
2020
Q4 		$20.6M Buy
197,100
+164,900
+512% +$16.7M ﹤0.01% 1861
2020
Q3 		$2.28M Buy
32,200
+300
+0.9% +$20.9K ﹤0.01% 3575
2020
Q2 		$2.05M Buy
+31,900
New +$1.75M ﹤0.01% 3616

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's MRNA Position: Q1 2026 in Review

Bank of America reduced its Moderna (MRNA) stake by 28% in Q1 2026, selling an estimated $18.1M and leaving 986,360 shares worth $50.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Bank of America first reported a position in MRNA in Q4 2018 and has held it in 30 quarters since. The position peaked at $308M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Bank of America held 986,360 shares of Moderna worth $50.1M as of Q1 2026.
  • Bank of America sold 388,494 Moderna shares in Q1 2026, an estimated $18.1M.
  • Moderna made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1592 holding.
  • Bank of America first reported a position in Moderna in Q4 2018 and has held it in 30 quarters since.
  • Bank of America's Moderna position peaked at $308M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.